Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function

Open access

Abstract

OBJECTIVE— Somatostatin (SST) is secreted by islet δ-cells and by extraislet neuroendocrine cells. SST receptors have been identified on α- and β-cells, and exogenous SST inhibits insulin and glucagon secretion, consistent with a role for SST in regulating α- and β-cell function. However, the specific intraislet function of δ-cell SST remains uncertain. We have used Sst−/− mice to investigate the role of δ-cell SST in the regulation of insulin and glucagon secretion in vitro and in vivo. RESEARCH DESIGN AND METHODS— Islet morphology was assessed by histological analysis. Hormone levels were measured by radioimmunoassay in control and Sst−/− mice in vivo and from isolated islets in vitro. RESULTS— Islet size and organization did not differ between Sst−/− and control islets, nor did islet glucagon or insulin content. Sst−/− mice showed enhanced insulin and glucagon secretory responses in vivo. In vitro stimulus-induced insulin and glucagon secretion was enhanced from perifused Sst−/− islets compared with control islets and was inhibited by exogenous SST in Sst−/− but not control islets. No difference in the switch-off rate of glucose-stimulated insulin secretion was observed between genotypes, but the cholinergic agonist carbamylcholine enhanced glucose-induced insulin secretion to a lesser extent in Sst−/− islets compared with controls. Glucose suppressed glucagon secretion from control but not Sst−/− islets. CONCLUSIONS— We suggest that δ-cell SST exerts a tonic inhibitory influence on insulin and glucagon secretion, which may facilitate the islet response to cholinergic activation. In addition, δ-cell SST is implicated in the nutrient-induced suppression of glucagon secretion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db08-0792

Cites

Statistics

Figures

FIG. 1. Intraislet organization of α- and β-cells from control and Sst−/− islets. Consecutive sections of control (A and B) or Sst−/− (C and D) mouse islets were stained for insulin (A and C) or glucagon (B and D), respectively, and are representative of sections from three different animals. (Please see http://dx.doi.org/10.2337/db08-0792 for a high-quality digital representation of this figure.)
FIG. 1. Intraislet organization of α- and β-cells from control and Sst−/− islets. Consecutive sections of control (A and B) or Sst−/− (C and D) mouse islets were stained for insulin (A and C) or glucagon (B and D), respectively, and are representative of sections from three different animals. (Please see http://dx.doi.org/10.2337/db08-0792 for a high-quality digital representation of this figure.)CC BY-NC-ND · PubMed Central
FIG. 2. Insulin and glucagon secretion in vivo. A: Plasma insulin levels in Sst−/− mice and control mice 0, 2, 5, and 15 min after an intravenous glucose challenge (0.5 g/kg). Points show means ± SE for four to six separate animals. B: Plasma glucagon levels in Sst−/− mice and control mice 0, 2, and 5 min after injection of intravenous arginine (0.25 g/kg). Points show means ± SE for 5 and 14 separate animals (Sst−/− and control, respectively). C: Plasma glucose levels in Sst−/− mice and control mice 0, 15, 30, 45, and 60 min after injection of intravenous insulin (0.4 units/kg). Points show means ± SE for five separate animals.
FIG. 2. Insulin and glucagon secretion in vivo. A: Plasma insulin levels in Sst−/− mice and control mice 0, 2, 5, and 15 min after an intravenous glucose challenge (0.5 g/kg). Points show means ± SE for four to six separate animals. B: Plasma glucagon levels in Sst−/− mice and control mice 0, 2, and 5 min after injection of intravenous arginine (0.25 g/kg). Points show means ± SE for 5 and 14 separate animals (Sst−/− and control, respectively). C: Plasma glucose levels in Sst−/− mice and control mice 0, 15, 30, 45, and 60 min after injection of intravenous insulin (0.4 units/kg). Points show means ± SE for five separate animals.CC BY-NC-ND · PubMed Central
FIG. 3. Hormone secretion from control and SST−/− islets. A: Insulin secretion from control and Sst−/− mouse islets at a substimulatory concentration of glucose (2 mmol/l G, 0–10 min) and at a stimulatory concentration of glucose (bar, 20 mmol/l G). Points show means ± SE, n = 7–8 separate perifusion channels in each experiment, typical of 10 separate experiments. In B, the same results are expressed as a percentage of total insulin content. C: Arginine-induced (20 mmol/l, bar) glucagon secretion from Sst−/− islets and control islets. Points show means ± SE, n = 4 perifusion channels. Where no error bars are shown, they are smaller than the size of the symbols. D: Insulin secretory responses to the sulfonylurea tolbutamide (100 μmol/l, bar) in the presence of 2 mmol/l glucose from Sst−/− islets and control islets. Points show means ± SE, n = 4 perifusion channels. E: SST secretion from control islets in response to glucose, tolbutamide, and arginine. Bars represent means ± SE, n = 8–9 in one experiment typical of three separate experiments. *P < 0.05, **P < 0.01 vs. 1 mmol/l glucose alone.
FIG. 3. Hormone secretion from control and SST−/− islets. A: Insulin secretion from control and Sst−/− mouse islets at a substimulatory concentration of glucose (2 mmol/l G, 0–10 min) and at a stimulatory concentration of glucose (bar, 20 mmol/l G). Points show means ± SE, n = 7–8 separate perifusion channels in each experiment, typical of 10 separate experiments. In B, the same results are expressed as a percentage of total insulin content. C: Arginine-induced (20 mmol/l, bar) glucagon secretion from Sst−/− islets and control islets. Points show means ± SE, n = 4 perifusion channels. Where no error bars are shown, they are smaller than the size of the symbols. D: Insulin secretory responses to the sulfonylurea tolbutamide (100 μmol/l, bar) in the presence of 2 mmol/l glucose from Sst−/− islets and control islets. Points show means ± SE, n = 4 perifusion channels. E: SST secretion from control islets in response to glucose, tolbutamide, and arginine. Bars represent means ± SE, n = 8–9 in one experiment typical of three separate experiments. *P < 0.05, **P < 0.01 vs. 1 mmol/l glucose alone.CC BY-NC-ND · PubMed Central
FIG. 4. Inhibition of insulin and glucagon secretion by exogenous SST. Effect of exogenous SST (1 μmol/l) on dynamic glucose-induced insulin secretion (20 mmol/l G, bar) (A) and static arginine-induced (20 mmol/l) glucagon secretion (B) from control islets and Sst−/− islets. Points show means ± SE, n = 4 separate perifusion channels in each experiment, typical of six separate experiments. Bars represent means ± SE, n = 6. ***P < 0.001 vs. arginine (Arg) alone.
FIG. 4. Inhibition of insulin and glucagon secretion by exogenous SST. Effect of exogenous SST (1 μmol/l) on dynamic glucose-induced insulin secretion (20 mmol/l G, bar) (A) and static arginine-induced (20 mmol/l) glucagon secretion (B) from control islets and Sst−/− islets. Points show means ± SE, n = 4 separate perifusion channels in each experiment, typical of six separate experiments. Bars represent means ± SE, n = 6. ***P < 0.001 vs. arginine (Arg) alone.CC BY-NC-ND · PubMed Central
FIG. 5. Rate of decline in insulin secretion from control and Sst−/− islets after removal of glucose stimulus. A: Glucose-induced (20 mmol/l G, bar) insulin secretion from Sst−/− islets and control islets is reversed to basal levels upon removal of stimulus. B: The decline in insulin secretion from stimulated to basal levels is expressed as percent stimulated insulin secretion before removal of glucose. Points show means ± SE, n = 4 separate perifusion channels.
FIG. 5. Rate of decline in insulin secretion from control and Sst−/− islets after removal of glucose stimulus. A: Glucose-induced (20 mmol/l G, bar) insulin secretion from Sst−/− islets and control islets is reversed to basal levels upon removal of stimulus. B: The decline in insulin secretion from stimulated to basal levels is expressed as percent stimulated insulin secretion before removal of glucose. Points show means ± SE, n = 4 separate perifusion channels.CC BY-NC-ND · PubMed Central
FIG. 6. Parasympathetic stimulation of insulin secretion from control and Sst−/− islets. Static insulin (A) and SST secretion (B) from control islets in response to glucose (20 mmol/l) and the cholinergic agonist CCh (500 μmol/l). Bars represent means ± SE, n = 8–9 in one experiment typical of three separate experiments. **P < 0.01 vs. 1 mmol/l glucose alone, ††P < 0.01, †††P > 0.001 vs. 20 mmol/l glucose. Data in A and B are from the same experiment. C: Effect of CCh (500 μmol/l) on dynamic glucose-induced (20 mmol/l G, bar) insulin secretion from control (○) and Sst−/− (•) islets. Fractions were collected every 1 min between 10 and 30 min and 50 and 60 min and every 30 s between 30 and 50 min. Points show means ± SE, n = 3 perifusion channels in one experiment representative of three separate experiments. D: The effect of CCh is expressed as a percentage stimulation of the glucose-induced (20 mmol/l) secretory response (mean amplitude of secretion at time points 31–40 min expressed as a percentage of mean amplitude at 21–30 min).
FIG. 6. Parasympathetic stimulation of insulin secretion from control and Sst−/− islets. Static insulin (A) and SST secretion (B) from control islets in response to glucose (20 mmol/l) and the cholinergic agonist CCh (500 μmol/l). Bars represent means ± SE, n = 8–9 in one experiment typical of three separate experiments. **P < 0.01 vs. 1 mmol/l glucose alone, ††P < 0.01, †††P > 0.001 vs. 20 mmol/l glucose. Data in A and B are from the same experiment. C: Effect of CCh (500 μmol/l) on dynamic glucose-induced (20 mmol/l G, bar) insulin secretion from control (○) and Sst−/− (•) islets. Fractions were collected every 1 min between 10 and 30 min and 50 and 60 min and every 30 s between 30 and 50 min. Points show means ± SE, n = 3 perifusion channels in one experiment representative of three separate experiments. D: The effect of CCh is expressed as a percentage stimulation of the glucose-induced (20 mmol/l) secretory response (mean amplitude of secretion at time points 31–40 min expressed as a percentage of mean amplitude at 21–30 min).CC BY-NC-ND · PubMed Central
FIG. 7. Glucose-induced suppression of glucagon secretion requires SST. A: Effect of high glucose concentration (20 mmol/l) on glucagon secretion from control islets (□) and Sst−/− islets (▪) in static incubations. Bars represent means ± SE, n = 5–7. *P < 0.05 vs. 2 mmol/l glucose. B: Glucose-induced insulin secretion from the same experiment. **P < 0.01, ***P < 0.001 vs. 2 mmol/l glucose. There was no significant increase in glucagon secretion from Sst−/− islets in response to glucose in seven separate experiments, although in three of these, secretion appeared higher (see A). C: Glucagon secretion from control islets (□) and Sst−/− islets (▪) in response to increasing glucose concentrations. Islets were preincubated in the absence of glucose for 1 h before exposure to the glucose concentrations shown in the figure. Bars represent means ± SE, n = 5–6. *P < 0.05 vs. 0 mmol/l glucose. D: Effect of 10 mmol/l glucose (G, bar) on dynamic glucagon secretion from control islets (○) and Sst−/− islets (•) preincubated in the absence of glucose for 20 min. Points show means ± SE, n = 4 perifusion channels. Controls, P < 0.001 for 0 vs. 10 mmol/l glucose mean values.
FIG. 7. Glucose-induced suppression of glucagon secretion requires SST. A: Effect of high glucose concentration (20 mmol/l) on glucagon secretion from control islets (□) and Sst−/− islets (▪) in static incubations. Bars represent means ± SE, n = 5–7. *P < 0.05 vs. 2 mmol/l glucose. B: Glucose-induced insulin secretion from the same experiment. **P < 0.01, ***P < 0.001 vs. 2 mmol/l glucose. There was no significant increase in glucagon secretion from Sst−/− islets in response to glucose in seven separate experiments, although in three of these, secretion appeared higher (see A). C: Glucagon secretion from control islets (□) and Sst−/− islets (▪) in response to increasing glucose concentrations. Islets were preincubated in the absence of glucose for 1 h before exposure to the glucose concentrations shown in the figure. Bars represent means ± SE, n = 5–6. *P < 0.05 vs. 0 mmol/l glucose. D: Effect of 10 mmol/l glucose (G, bar) on dynamic glucagon secretion from control islets (○) and Sst−/− islets (•) preincubated in the absence of glucose for 20 min. Points show means ± SE, n = 4 perifusion channels. Controls, P < 0.001 for 0 vs. 10 mmol/l glucose mean values.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 47 · Cited by 335

Metadata

Authors
Hauge-Evans, A. C., King, A. J., Carmignac, D., Richardson, C. C., Robinson, I. C. A. F., Low, M. J., Christie, M. R., Persaud, S. J., & Jones, P. M.
Affiliations
  • King's College London (GB)
  • National Institute for Medical Research (GB)
  • Oregon Health & Science University (US)
Venue
Diabetes
Published
2009-02-01
Volume
58
Issue
2
Pages
403-411
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2150567837
Cited by
335
References
47
Citations by year
2026: 22 · 2025: 17 · 2024: 29 · 2023: 15 · 2022: 16 · 2021: 21 · 2020: 26 · 2019: 17 · 2018: 24 · 2017: 10 · 2016: 20 · 2015: 24 · 2014: 22 · 2013: 14 · 2012: 13
FWCI
15.46
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Lincoln Repository (University of Lincoln) (acceptedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
somatostatin, delta cells, paracrine regulation, insulin secretion, glucagon secretion, islet function, cholinergic stimulation, glucose-stimulated insulin secretion, glucagon suppression, alpha cells, pancreatic beta cells
MeSH terms
Insulin Secretion, Animals, Female, Glucagon, Immunohistochemistry, Insulin, Islets of Langerhans, Male, Radioimmunoassay, Somatostatin, Polymerase Chain Reaction, Mice, Knockout, Somatostatin-Secreting Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function. https://app.cochat.ai/papers/10.2337/db08-0792
The paper
Hauge-Evans, A. C., King, A. J., Carmignac, D., Richardson, C. C., Robinson, I. C. A. F., Low, M. J., Christie, M. R., Persaud, S. J., & Jones, P. M. (2009). Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function. Diabetes. https://doi.org/10.2337/db08-0792

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.